✦ LIBER ✦

Insulin-like growth factors and breast cancer

✍ Scribed by AV Lee; D Yee

Book ID: 116152546
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 712 KB
Volume: 49
Category: Article
ISSN: 0753-3322
DOI: 10.1016/0753-3322(96)82678-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The insulin-like growth factors and brea

The insulin-like growth factors and breast cancer — revisited

✍ Douglas Yee 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 201 KB

Insulin-like growth factor binding prote

Insulin-like growth factor binding proteins and breast cancer

✍ Ashok Subramanian; Anup Sharma; Kefah Mokbel 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 368 KB

Serum insulin-like growth factor-I and b

Serum insulin-like growth factor-I and breast cancer

✍ Paolo Toniolo; Peter F. Bruning; Arslan Akhmedkhanov; Johannes M.G. Bonfrer; Kar 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 57 KB 👁 2 views

Targeting Insulin and Insulin-Like Growt

Targeting Insulin and Insulin-Like Growth Factor Signaling in Breast Cancer

✍ Yuzhe Yang, Douglas Yee 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 334 KB

Insulin-like growth factor-1 receptors a

Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer

✍ John A. Foekens; Henk Portengen; Manon Janssen; Jan G. M. Klijn 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 915 KB

In the current study the authors have investigated whether human primary breast cancer specimens contain insulin-like growth factor-1 (IGF-1) receptors (IGF-1-R) or IGF-1-like activities. Simultaneously, epidermal growth factor (EGF) receptors (EGF-R) and cytosolic estrogen receptor (ER), progestero

Free insulin-like growth factor-I and br

Free insulin-like growth factor-I and breast cancer risk

✍ Benjamin D.L. Li; M. Javad Khosravi; Hans J. Berkel; Anastasia Diamandi; Mark A. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 56 KB 👁 2 views

Insulin-like growth factor-I (IGF-I) has mitogenic and antiapoptotic effects on breast cancer cells. Epidemiologic studies have shown that high plasma levels of IGF-I and low levels of IGF binding protein (BP)-3 are associated with increased risk of breast cancer in premenopausal women. The actions